Cargando…

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas

Gliomas are one of the most frequent types of nervous system tumours and have significant morbidity and mortality rates. As a result, it is critical to fully comprehend the molecular mechanism of glioma to predict prognosis and target gene therapy. The goal of this research was to discover the hub g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Shiao, Xia, Minqi, Xu, Yang, Sun, Qian, Ye, Liguo, Cai, Jiayang, Ye, Zhang, Tian, Daofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556650/ https://www.ncbi.nlm.nih.gov/pubmed/36248799 http://dx.doi.org/10.3389/fimmu.2022.1000396

Ejemplares similares

Identification and validation of a novel prognostic signature based on mitochondria and oxidative stress related genes for glioblastoma
por: Tong, Shiao, et al.
Publicado: (2023)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas()
por: Tong, Shiao, et al.
Publicado: (2022)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
por: Ye, Liguo, et al.
Publicado: (2021)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
por: Xu, Yang, et al.
Publicado: (2021)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
por: Zhang, Chunyu, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development
por: Ye, Liguo, et al.
Publicado: (2021)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
por: Bao, Jia-hao, et al.
Publicado: (2022)

Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
por: Zeng, Yu, et al.
Publicado: (2022)

Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease
por: Zhao, Songyun, et al.
Publicado: (2023)

Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma
por: Feng, Shaobin, et al.
Publicado: (2021)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Sun, Qi, et al.
Publicado: (2021)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
por: Deng, Yulin, et al.
Publicado: (2022)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma
por: Cai, Jiayang, et al.
Publicado: (2023)

TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells
por: Gao, Lun, et al.
Publicado: (2023)

Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification
por: Peng, Zesheng, et al.
Publicado: (2023)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

Construction and validation of chemoresistance-associated tumor- infiltrating exhausted-like CD8+ T cell signature in breast cancer: cr-TILCD8TSig
por: Cai, DQ., et al.
Publicado: (2023)

A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma
por: Lei, Qiang, et al.
Publicado: (2023)

A Potential Probiotic for Diarrhea: Clostridium tyrobutyricum Protects Against LPS-Induced Epithelial Dysfunction via IL-22 Produced By Th17 Cells in the Ileum
por: Xiao, Zhiping, et al.
Publicado: (2021)

Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy
por: Xia, Minqi, et al.
Publicado: (2022)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
por: Ait Ssi, Saadia, et al.
Publicado: (2021)

Machine learning-based identification of SOX10 as an immune regulator of macrophage in gliomas
por: Xiao, Gelei, et al.
Publicado: (2022)

Identification and Validation of the Signatures of Infiltrating Immune Cells in the Eutopic Endometrium Endometria of Women With Endometriosis
por: Wu, Xiang-Guang, et al.
Publicado: (2021)

Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma
por: Fan, Yang, et al.
Publicado: (2022)

Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification
por: Gliddon, Harriet D., et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rj8148c4i58hd27jsn090ka0ha